ESTRO 2025 - Abstract Book

S3498

Physics - Optimisation, algorithms and applications for ion beam treatment planning

ESTRO 2025

Conclusion: The use of MCAA reduced OAR dose for all TET patients at virtually no cost except a marginally longer planning and fraction time. Whether the dose reductions are sufficient to have clinical impact remains to be seen.

Keywords: Thymoma, proton therapy, lateral penumbra trimming